If to look deeply and make approximation to other types of tumors, the link between functionality of AID and malignancies becomes more transparent and logical: cancer cells acquire tumor-specific DNA alterations, including multiple somatic mutations of tumor-promoting genes and/or recurrent chromosomal translocations and their corresponding gene fusions at the precise timing during cellular development. The gene discussed is AICDA; the disease is cancer.